BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15364410)

  • 1. Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis.
    Martínez-Torres FJ; Wagner S; Haas J; Kehm R; Sellner J; Hacke W; Meyding-Lamadé U
    Neurosci Lett; 2004 Sep; 368(3):274-8. PubMed ID: 15364410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue.
    Dvorak F; Martinez-Torres F; Sellner J; Haas J; Schellinger PD; Schwaninger M; Meyding-Lamadé UK
    Neurosci Lett; 2004 Sep; 367(3):289-92. PubMed ID: 15337251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus.
    Maolood N; Hardin-Pouzet H; Grange-Messent V
    Eur J Neurosci; 2008 Mar; 27(5):1143-52. PubMed ID: 18364034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits.
    Yongxin S; Wenjun D; Qiang W; Yunqing S; Liming Z; Chunsheng W
    Ann Thorac Surg; 2013 Jan; 95(1):55-61. PubMed ID: 23146278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for matrix metalloproteinases in granulocyte infiltration and testicular remodelation in a seasonal breeding teleost.
    Chaves-Pozo E; Castillo-Briceño P; García-Alcázar A; Meseguer J; Mulero V; García-Ayala A
    Mol Immunol; 2008 May; 45(10):2820-30. PubMed ID: 18342940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis.
    Dang AB; Tay BK; Kim HT; Nauth A; Alfonso-Jaume MA; Lovett DH
    Spine (Phila Pa 1976); 2008 Aug; 33(17):E576-9. PubMed ID: 18670324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection.
    Hlawaty H; San Juan A; Jacob MP; Vranckx R; Letourneur D; Feldman LJ
    J Gene Med; 2009 Jan; 11(1):92-9. PubMed ID: 19040207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.
    Zhou Y; Lu ZN; Guo YJ; Mei YW
    Neurol Res; 2010 Oct; 32(8):801-9. PubMed ID: 20483026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases in the neurogenic niche of the adult monkey hippocampus after ischemia.
    Lu L; Tonchev AB; Kaplamadzhiev DB; Boneva NB; Mori Y; Sahara S; Ma D; Nakaya MA; Kikuchi M; Yamashima T
    Hippocampus; 2008; 18(10):1074-84. PubMed ID: 18566964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of MMP2 and MMP9 expression in prostate cancer].
    Zhang XY; Hong BF; Chen GF; Lu YL; Zhong M
    Zhonghua Nan Ke Xue; 2005 May; 11(5):359-61, 364. PubMed ID: 15934460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation.
    Sellner J; Simon F; Meyding-Lamade U; Leib SL
    Brain Res; 2006 Dec; 1125(1):155-62. PubMed ID: 17109833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of triptolide on the expression of matrix metalloproteinases 2 and 9 in lungs of experimental pulmonary hypertension].
    Wei L; Liu T; Liu B; Wang XM; Zhao L; Zhou TF
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):479-83. PubMed ID: 17937863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis.
    Sellner J; Dvorak F; Zhou Y; Haas J; Kehm R; Wildemann B; Meyding-Lamadè U
    Neurosci Lett; 2005 Feb; 374(3):197-202. PubMed ID: 15663962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats.
    Pustovrh MC; Jawerbaum A; White V; Capobianco E; Higa R; Martínez N; López-Costa JJ; González E
    Reproduction; 2007 Oct; 134(4):605-13. PubMed ID: 17890296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mRNA expression of neurotrophic factors GDNF, BDNF, and NT-3 in experimental herpes simplex virus encephalitis.
    Sellner J; Lenhard T; Haas J; Einsiedel Rv; Meyding-Lamadé U
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):267-71. PubMed ID: 15950786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer.
    Somiari SB; Shriver CD; Heckman C; Olsen C; Hu H; Jordan R; Arciero C; Russell S; Garguilo G; Hooke J; Somiari RI
    Cancer Lett; 2006 Feb; 233(1):98-107. PubMed ID: 16473671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.